We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Characterization of Epileptic Motor Patterns by Tridimensional Analysis of Movement 2 (CAPAMETRIM2)

This study has been terminated.
(departure of a collaborator in charge of the data collection)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01025401
First Posted: December 3, 2009
Last Update Posted: November 23, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University Hospital, Grenoble
  Purpose

CAPAMETRIM 2 aims to characterize epileptic motor patterns by a quantitative three-dimensional analysis of movements.

This is done to obtain a 3-D motor signature of seizures, for a given patient, and allows their detection with an ambulatory monitoring system.

The benefit for patients is to improve the diagnosis of their diseases by better characterizing their seizures.


Condition Intervention
Epileptic Patients With Motor Manifestations During Seizures Device: 3-D accelerometric and magnetic sensors

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: Caractérisation et détection Des Mouvements Durant Les Crises d'épilepsie à Des Fins d'Alarme, Pour un Usage en Institution et en Famille.

Resource links provided by NLM:


Further study details as provided by University Hospital, Grenoble:

Primary Outcome Measures:
  • 3-D accelerometric and magnetic sensors [ Time Frame: continuously during hospitalization recordings (46 Hz from 9 h to 17 h) ]

Secondary Outcome Measures:
  • Video [ Time Frame: continuously during hospitalization recordings (25 fps from 9 h to 17 h) ]
  • EEG [ Time Frame: continuously during hospitalization recordings (256-1024 Hz from 9 h to 17 h) ]

Enrollment: 50
Study Start Date: May 2009
Study Completion Date: October 2010
Primary Completion Date: October 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: Motor manifestations during seizures Device: 3-D accelerometric and magnetic sensors
sensors are positioned on the right wrist, the left wrist and on the head.

Detailed Description:

CAPAMETRIM 2 aims to characterize epileptic motor patterns by a quantitative three-dimensional analysis of movements.

The project is planned in three phases:

  • Installation of 3-D accelerometric and magnetic sensors acquisition systems on the hospital (extension of a preceding study CAPAMETRIM).
  • Collection of data on epileptic patients. Sensors will be positioned on the right and left hands and on the head. A 3-D analysis of movements will be done according to the collection by tagging data with visual analysis made on video.
  • Development of a motor pattern classification system used for seizure detection.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   6 Years and older   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Adult or children (>= 6 years)
  • Written inform consented from the patient or its legal representative
  • Presurgical investigation of pharmaco-resistant partial epilepsy
  • Motor manifestations during seizures

Exclusion Criteria:

  • Proved generalized epilepsy
  • No motor manifestations during seizures
  • Pregnant women
  • Subjects deprived of freedom by an administrative or judicial decision
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01025401


Locations
France
Grenoble University Hospital Epilepsy Monitoring Unit
Grenoble, France, 38043
Sponsors and Collaborators
University Hospital, Grenoble
Investigators
Principal Investigator: Philippe Kahane, MD PHD University Hospital, Grenoble
  More Information

Responsible Party: Philippe KAHANE/MD-PHD, University Hospital, Grenoble
ClinicalTrials.gov Identifier: NCT01025401     History of Changes
Other Study ID Numbers: 0905
2009-A00196-51 ( Registry Identifier: ID RCB )
First Submitted: June 29, 2009
First Posted: December 3, 2009
Last Update Posted: November 23, 2010
Last Verified: November 2010

Keywords provided by University Hospital, Grenoble:
epilepsy
seizures
movement

Additional relevant MeSH terms:
Seizures
Epilepsy
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Neurologic Manifestations
Signs and Symptoms